Cargando…

The potential use of biomarkers in predicting contrast-induced acute kidney injury

Contrast-induced acute kidney injury (CI-AKI) is a problem associated with the use of iodinated contrast media, causing kidney dysfunction in patients with preexisting renal failure. It accounts for 12% of all hospital-acquired kidney failure and increases the length of hospitalization, a situation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andreucci, Michele, Faga, Teresa, Riccio, Eleonora, Sabbatini, Massimo, Pisani, Antonio, Michael, Ashour
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024777/ https://www.ncbi.nlm.nih.gov/pubmed/27672338 http://dx.doi.org/10.2147/IJNRD.S105124

Ejemplares similares

Acute Kidney Injury by Radiographic Contrast Media: Pathogenesis and Prevention
por: Andreucci, Michele, et al.
Publicado: (2014)

Prevention of Contrast-Induced Nephropathy through a Knowledge of Its Pathogenesis and Risk Factors
por: Andreucci, Michele, et al.
Publicado: (2014)

Molecular Mechanisms of Renal Cellular Nephrotoxicity due to Radiocontrast Media
por: Michael, Ashour, et al.
Publicado: (2014)

Role of Reactive Oxygen Species in Pathogenesis of Radiocontrast-Induced Nephropathy
por: Pisani, Antonio, et al.
Publicado: (2013)

Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
por: Riccio, Eleonora, et al.
Publicado: (2015)

Update on the renal toxicity of iodinated contrast drugs used in clinical medicine
por: Andreucci, Michele, et al.
Publicado: (2017)

Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?
por: Pisani, Antonio, et al.
Publicado: (2018)

Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
por: Pisani, Antonio, et al.
Publicado: (2015)

Hypoxia-Inducible Factor Stabilizers in End Stage Kidney Disease: “Can the Promise Be Kept?”
por: Crugliano, Giuseppina, et al.
Publicado: (2021)

The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients
por: Provenzano, Michele, et al.
Publicado: (2020)

OMICS in Chronic Kidney Disease: Focus on Prognosis and Prediction
por: Provenzano, Michele, et al.
Publicado: (2021)

Darbepoetin alfa reduces cell death due to radiocontrast media in human renal proximal tubular cells
por: Andreucci, Michele, et al.
Publicado: (2021)

RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study
por: Riccio, Eleonora, et al.
Publicado: (2022)

Renal resistive index in chronic kidney disease patients: Possible determinants and risk profile
por: Provenzano, Michele, et al.
Publicado: (2020)

Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases
por: Andreucci, Michele, et al.
Publicado: (2021)

The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?
por: Provenzano, Michele, et al.
Publicado: (2020)

Risk factors for acute kidney injury and mortality in high risk patients undergoing cardiac surgery
por: Serraino, Giuseppe Filiberto, et al.
Publicado: (2021)

Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease
por: Provenzano, Michele, et al.
Publicado: (2020)

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
por: Riccio, Eleonora, et al.
Publicado: (2020)

Novel Biomarkers for Contrast-Induced Acute Kidney Injury
por: Briguori, Carlo, et al.
Publicado: (2014)

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer
por: Carlomagno, Nicola, et al.
Publicado: (2017)

Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020)

The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization
por: Serra, Raffaele, et al.
Publicado: (2021)

The Potential Biotherapeutic Targets of Contrast-Induced Acute Kidney Injury
por: Cheng, Alice Shasha, et al.
Publicado: (2023)

COVID-19 and the Kidney: From Epidemiology to Clinical Practice
por: Gagliardi, Ida, et al.
Publicado: (2020)

Side Effects of Radiographic Contrast Media
por: Andreucci, Michele
Publicado: (2014)

Contrast-induced Acute Kidney Injury
por: Ramachandran, Pratheema, et al.
Publicado: (2020)

Contrast-Associated Acute Kidney Injury
por: Mandurino-Mirizzi, Alessandro, et al.
Publicado: (2022)

Diet and Other Modifiable Factors in Long-Term Decline of Kidney Function: Observational and Population-Based Cohort Study
por: Cirillo, Massimo, et al.
Publicado: (2023)

Dickkopf-3 in the prediction of contrast media induced acute kidney injury
por: Seibert, Felix S., et al.
Publicado: (2020)

Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis
por: Capuano, Ivana, et al.
Publicado: (2022)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

A strange epigastric pain
por: Riccio, Eleonora, et al.
Publicado: (2014)

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
por: Cammarata, Giuseppe, et al.
Publicado: (2018)

Contrast-induced Acute Kidney Injury and Inflammation
por: Yun, Kyeong Ho
Publicado: (2017)

Metformin, arterial contrast and acute kidney injury
por: Amos, Lal, et al.
Publicado: (2019)

The conundrum of contrast-induced acute kidney injury
por: Haq, Mohammad Faraz Ul, et al.
Publicado: (2020)

Fanconi syndrome with lysinuric protein intolerance
por: Riccio, Eleonora, et al.
Publicado: (2014)

Idiosyncratic hepatic toxicity in autosomal dominant polycystic kidney disease (ADPKD) patient in combined treatment with tolvaptan and amoxicillin/clavulanic acid: a case report
por: Pellegrino, Angela Maria, et al.
Publicado: (2019)

Urinary NGAL, IGFBP-7, and TIMP-2: novel biomarkers to predict contrast medium-induced acute kidney injury in children
por: Sun, Qianliang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bar82jnv9dfq1e9a5sv7mj6fq5